Literature DB >> 1655175

Adsorption and mineralization effects of citrate and phosphocitrate on hydroxyapatite.

M Johnsson1, C F Richardson, J D Sallis, G H Nancollas.   

Abstract

The adsorption of citrate and phosphocitrate ions by hydroxyapatite (HAP) surfaces and their influence on the constant composition growth kinetics of HAP have been investigated. Phosphocitrate was strongly adsorbed to HAP and inhibited crystal growth. When HAP surfaces containing preadsorbed citrate were exposed to phosphocitrate, the uptake of the latter markedly increased. The two additives behaved synergistically in their HAP crystal growth inhibition.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1655175     DOI: 10.1007/bf02565136

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  8 in total

1.  Pyrophosphatase and ATPase of isolated cartilage matrix vesicles.

Authors:  R Felix; H Fleisch
Journal:  Calcif Tissue Res       Date:  1976-11-24

2.  Studies on urinary stone formation: a saga of clinical investigation.

Authors:  J E Howard
Journal:  Johns Hopkins Med J       Date:  1976-12

3.  Mineralization kinetics: a constant composition approach.

Authors:  M B Tomson; G H Nancollas
Journal:  Science       Date:  1978-06-02       Impact factor: 47.728

4.  Role of ATP and Mg in the stabilization of biological and synthetic amorphous calcium phosphates.

Authors:  A S Posner; F Betts; N C Blumenthal
Journal:  Calcif Tissue Res       Date:  1977-05

5.  Structural factors influencing the ability of compounds to inhibit hydroxyapatite formation.

Authors:  G Williams; J D Sallis
Journal:  Calcif Tissue Int       Date:  1982-03       Impact factor: 4.333

6.  The synthesis of unlabeled and 32P-labeled phosphocitrate and analytical systems for its identification.

Authors:  G Williams; J D Sallis
Journal:  Anal Biochem       Date:  1980-03-01       Impact factor: 3.365

7.  Structure--activity relationship of inhibitors of hydroxyapatite formation.

Authors:  G Williams; J D Sallis
Journal:  Biochem J       Date:  1979-10-15       Impact factor: 3.857

8.  Synthesis and characterization of phosphocitric acid, a potent inhibitor of hydroxylapatite crystal growth.

Authors:  W P Tew; C Mahle; J Benavides; J E Howard; A L Lehninger
Journal:  Biochemistry       Date:  1980-04-29       Impact factor: 3.162

  8 in total
  6 in total

1.  How to control the size and morphology of apatite nanocrystals in bone.

Authors:  Baoquan Xie; George H Nancollas
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-17       Impact factor: 11.205

Review 2.  Pathophysiology-based treatment of idiopathic calcium kidney stones.

Authors:  Fredric L Coe; Andrew Evan; Elaine Worcester
Journal:  Clin J Am Soc Nephrol       Date:  2011-08       Impact factor: 8.237

3.  Role of Phosphorus-Containing Molecules on the Formation of Nano-Sized Calcium Phosphate for Bone Therapy.

Authors:  Yingying Jiang; Yali Tao; Yutong Chen; Xu Xue; Gangyi Ding; Sicheng Wang; Guodong Liu; Mengmeng Li; Jiacan Su
Journal:  Front Bioeng Biotechnol       Date:  2022-06-22

4.  Apatite formation on collagen fibrils in the presence of polyacrylic acid.

Authors:  E K Girija; Y Yokogawa; F Nagata
Journal:  J Mater Sci Mater Med       Date:  2004-05       Impact factor: 3.896

5.  Adsorption and modification of calcium salt crystal growth by anionic peptides and spermine.

Authors:  E Mueller; C S Sikes
Journal:  Calcif Tissue Int       Date:  1993-01       Impact factor: 4.333

6.  Functionalizing calcium phosphate biomaterials with antibacterial silver particles.

Authors:  Jae Sung Lee; William L Murphy
Journal:  Adv Mater       Date:  2012-11-26       Impact factor: 30.849

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.